Cosopt (Dorzolamide Hydrochloride / Timolol Maleate Ophthalmic) - Current Clinical Trials

Cosopt Related Clinical Trials

12-Month Stability of Diurnal IOP Control on Cosopt [Active, not recruiting]

Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma. [Recruiting]

A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt [Recruiting]

Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension [Active, not recruiting]

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [Completed]

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT [Recruiting]

A Study to Evaluate The Effectiveness of Cosopt® as First Line Therapy [Completed]

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension [Recruiting]

Lumigan Versus Cosopt [Completed]

Cosopt Versus Xalatan [Completed]

Cosopt Versus Xalacom [Completed]

Assessing Cosopt Switch Patients [Completed]

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus Cosopt [Recruiting]

MK0507A Phase III Double-Blind, Comparative Study [Completed]